For decades, MIT Sloan Professor Lotte Bailyn has been calling for changes in the way work is organized -- often in ways that have proven prescient.
By
MIT researchers have developed a methodology for systematically tracking the outcomes of academic licensing transactions as a means of increasing funding to bridging the “valley of death.”
Researchers launched an in-house Data Science and Artificial Intelligence (DSAI) challenge to beat MIT’s machine-learning models for predicting clinical trial outcomes. The results are now available.
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
By
The studies describe new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines.
By
A new study led by MIT Sloan Prof. Andrew W. Lo finds that borrowing ideas and tools from the gaming community can improve online teaching techniques and improve learning outcomes for students.
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
This 2019 MIT Sloan case by Zeynep Ton and Katie Bach describes how the executive team at Mud Bay, a privately held pet store chain based in Olympia, Washington, implemented a good jobs strategy by offering better wages and benefits and seeking to recoup the costs by increasing sales growth and lowe...
By
During September's iLead Speaker Series event, Analysis Group’s Martha Samuelson, SF ’86, and Rebecca Kirk Fair, MBA ’02, discussed their professional journeys, as well as the culture and leadership of their firm.
By
Over 1,300 Sloanies and their guests returned to campus in early June to attend MIT Sloan Reunion 2023.
